
Abhishek Sarma
Examiner (ID: 5655, Phone: (571)272-9887 , Office: P/2697 )
| Most Active Art Unit | 2622 |
| Art Unit(s) | 2621, 2622, 2697 |
| Total Applications | 894 |
| Issued Applications | 742 |
| Pending Applications | 77 |
| Abandoned Applications | 104 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5136469
[patent_doc_number] => 20070078098
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-05
[patent_title] => 'Anti-hypercholesterolemic compounds'
[patent_app_type] => utility
[patent_app_number] => 11/542966
[patent_app_country] => US
[patent_app_date] => 2006-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13039
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0078/20070078098.pdf
[firstpage_image] =>[orig_patent_app_number] => 11542966
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/542966 | Anti-hypercholesterolemic compounds | Oct 3, 2006 | Issued |
Array
(
[id] => 4971994
[patent_doc_number] => 20070111997
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-17
[patent_title] => 'Triazolopyrimidines and related analogs as HSP90-inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/537017
[patent_app_country] => US
[patent_app_date] => 2006-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25431
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 27
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20070111997.pdf
[firstpage_image] =>[orig_patent_app_number] => 11537017
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/537017 | Triazolopyrimidines and related analogs as HSP90-inhibitors | Sep 28, 2006 | Abandoned |
Array
(
[id] => 4971993
[patent_doc_number] => 20070111996
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-17
[patent_title] => 'Pyrazolopyrimidines and related analogs as HSP90-inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/537002
[patent_app_country] => US
[patent_app_date] => 2006-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35783
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 59
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20070111996.pdf
[firstpage_image] =>[orig_patent_app_number] => 11537002
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/537002 | Pyrazolopyrimidines and related analogs as HSP90-inhibitors | Sep 28, 2006 | Abandoned |
Array
(
[id] => 5564693
[patent_doc_number] => 20090137546
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-28
[patent_title] => 'Anti-Hypercholesterolemic Compounds'
[patent_app_type] => utility
[patent_app_number] => 11/992990
[patent_app_country] => US
[patent_app_date] => 2006-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13035
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20090137546.pdf
[firstpage_image] =>[orig_patent_app_number] => 11992990
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/992990 | Anti-Hypercholesterolemic Compounds | Sep 28, 2006 | Abandoned |
Array
(
[id] => 5285541
[patent_doc_number] => 20090099216
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-16
[patent_title] => 'NOVEL ADENINE COMPOUND'
[patent_app_type] => utility
[patent_app_number] => 12/067781
[patent_app_country] => US
[patent_app_date] => 2006-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18415
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20090099216.pdf
[firstpage_image] =>[orig_patent_app_number] => 12067781
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/067781 | NOVEL ADENINE COMPOUND | Sep 21, 2006 | Abandoned |
Array
(
[id] => 5586010
[patent_doc_number] => 20090105212
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-23
[patent_title] => 'NOVEL ADENINE COMPOUND'
[patent_app_type] => utility
[patent_app_number] => 12/067651
[patent_app_country] => US
[patent_app_date] => 2006-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31215
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20090105212.pdf
[firstpage_image] =>[orig_patent_app_number] => 12067651
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/067651 | NOVEL ADENINE COMPOUND | Sep 21, 2006 | Abandoned |
Array
(
[id] => 5380314
[patent_doc_number] => 20090192153
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-30
[patent_title] => 'NOVEL ADENINE COMPOUND'
[patent_app_type] => utility
[patent_app_number] => 12/067780
[patent_app_country] => US
[patent_app_date] => 2006-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35427
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20090192153.pdf
[firstpage_image] =>[orig_patent_app_number] => 12067780
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/067780 | NOVEL ADENINE COMPOUND | Sep 20, 2006 | Abandoned |
Array
(
[id] => 4860390
[patent_doc_number] => 20080269240
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-30
[patent_title] => 'Novel Adenine Compound'
[patent_app_type] => utility
[patent_app_number] => 12/067446
[patent_app_country] => US
[patent_app_date] => 2006-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47900
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20080269240.pdf
[firstpage_image] =>[orig_patent_app_number] => 12067446
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/067446 | Novel Adenine Compound | Sep 20, 2006 | Abandoned |
Array
(
[id] => 5290993
[patent_doc_number] => 20090023723
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-22
[patent_title] => 'Purinone derivatives for treating neurodegenerative diseases'
[patent_app_type] => utility
[patent_app_number] => 11/534096
[patent_app_country] => US
[patent_app_date] => 2006-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17867
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0023/20090023723.pdf
[firstpage_image] =>[orig_patent_app_number] => 11534096
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/534096 | Purinone derivatives for treating neurodegenerative diseases | Sep 20, 2006 | Abandoned |
Array
(
[id] => 5509125
[patent_doc_number] => 20090082332
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-26
[patent_title] => 'PURINE DERIVATIVES FOR THE TREATMENT OF VIRAL OR ALLERGIC DISEASES AND CANCERS'
[patent_app_type] => utility
[patent_app_number] => 12/067536
[patent_app_country] => US
[patent_app_date] => 2006-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16395
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20090082332.pdf
[firstpage_image] =>[orig_patent_app_number] => 12067536
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/067536 | PURINE DERIVATIVES FOR THE TREATMENT OF VIRAL OR ALLERGIC DISEASES AND CANCERS | Sep 19, 2006 | Abandoned |
Array
(
[id] => 5265578
[patent_doc_number] => 20090118263
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-07
[patent_title] => 'Novel Adenine Compound'
[patent_app_type] => utility
[patent_app_number] => 12/067649
[patent_app_country] => US
[patent_app_date] => 2006-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39505
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20090118263.pdf
[firstpage_image] =>[orig_patent_app_number] => 12067649
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/067649 | Novel Adenine Compound | Sep 19, 2006 | Abandoned |
Array
(
[id] => 560719
[patent_doc_number] => 07470786
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-12-30
[patent_title] => 'Method for manufacture of ceftriaxone sodium'
[patent_app_type] => utility
[patent_app_number] => 11/532469
[patent_app_country] => US
[patent_app_date] => 2006-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15004
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/470/07470786.pdf
[firstpage_image] =>[orig_patent_app_number] => 11532469
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/532469 | Method for manufacture of ceftriaxone sodium | Sep 14, 2006 | Issued |
Array
(
[id] => 7693769
[patent_doc_number] => 20070015917
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-18
[patent_title] => 'Method For Manufacture of Ceftriaxone Sodium'
[patent_app_type] => utility
[patent_app_number] => 11/532485
[patent_app_country] => US
[patent_app_date] => 2006-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15214
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20070015917.pdf
[firstpage_image] =>[orig_patent_app_number] => 11532485
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/532485 | Method For Manufacture of Ceftriaxone Sodium | Sep 14, 2006 | Abandoned |
Array
(
[id] => 5496615
[patent_doc_number] => 20090264643
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-22
[patent_title] => 'Process for The Preparation of Beta-Lactam Antibiotic'
[patent_app_type] => utility
[patent_app_number] => 11/991624
[patent_app_country] => US
[patent_app_date] => 2006-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5088
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0264/20090264643.pdf
[firstpage_image] =>[orig_patent_app_number] => 11991624
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/991624 | Process for the preparation of beta-lactam antibiotic meropenem trihydrate | Sep 14, 2006 | Issued |
Array
(
[id] => 5160439
[patent_doc_number] => 20070173483
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-26
[patent_title] => 'Pyrrolopyrimidines and Related Analogs as HSP90-Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/531218
[patent_app_country] => US
[patent_app_date] => 2006-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46442
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0173/20070173483.pdf
[firstpage_image] =>[orig_patent_app_number] => 11531218
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/531218 | Pyrrolopyrimidines and Related Analogs as HSP90-Inhibitors | Sep 11, 2006 | Abandoned |
Array
(
[id] => 5576038
[patent_doc_number] => 20090143400
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-04
[patent_title] => 'PURINE DERIVATIVES HAVING IMMUNO-MODULATING PROPERTIES'
[patent_app_type] => utility
[patent_app_number] => 12/066952
[patent_app_country] => US
[patent_app_date] => 2006-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10292
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20090143400.pdf
[firstpage_image] =>[orig_patent_app_number] => 12066952
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/066952 | PURINE DERIVATIVES HAVING IMMUNO-MODULATING PROPERTIES | Sep 11, 2006 | Abandoned |
Array
(
[id] => 5101802
[patent_doc_number] => 20070185064
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-09
[patent_title] => '2-Aminopurine Analogs Having HSP90-Inhibiting Activity'
[patent_app_type] => utility
[patent_app_number] => 11/531221
[patent_app_country] => US
[patent_app_date] => 2006-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48111
[patent_no_of_claims] => 72
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0185/20070185064.pdf
[firstpage_image] =>[orig_patent_app_number] => 11531221
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/531221 | 2-Aminopurine Analogs Having HSP90-Inhibiting Activity | Sep 11, 2006 | Abandoned |
Array
(
[id] => 4705181
[patent_doc_number] => 20080064705
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-13
[patent_title] => 'Theophylline-based nitophenylpiperazine derivatives for enhancing aortic smooth muscle relaxation'
[patent_app_type] => utility
[patent_app_number] => 11/520174
[patent_app_country] => US
[patent_app_date] => 2006-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 6913
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20080064705.pdf
[firstpage_image] =>[orig_patent_app_number] => 11520174
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/520174 | Theophylline-based nitophenylpiperazine derivatives for enhancing aortic smooth muscle relaxation | Sep 11, 2006 | Abandoned |
Array
(
[id] => 5016636
[patent_doc_number] => 20070259845
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-08
[patent_title] => 'Processes for the preparation of (3R,4S)-4-((4-benzyloxy)phenyl)-1-(4-fluorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)-2-azetidinone, an intermediate for the synthesis of ezetimibe'
[patent_app_type] => utility
[patent_app_number] => 11/517704
[patent_app_country] => US
[patent_app_date] => 2006-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10223
[patent_no_of_claims] => 81
[patent_no_of_ind_claims] => 36
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0259/20070259845.pdf
[firstpage_image] =>[orig_patent_app_number] => 11517704
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/517704 | Processes for the preparation of (3R,4S)-4-((4-benzyloxy)phenyl)-1-(4-fluorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)-2-azetidinone, an intermediate for the synthesis of ezetimibe | Sep 7, 2006 | Abandoned |
Array
(
[id] => 5063664
[patent_doc_number] => 20070225304
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-27
[patent_title] => 'AMINOPURINE DERIVATIVES FOR TREATING NEURODEGENERATIVE DISEASES'
[patent_app_type] => utility
[patent_app_number] => 11/470347
[patent_app_country] => US
[patent_app_date] => 2006-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8552
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0225/20070225304.pdf
[firstpage_image] =>[orig_patent_app_number] => 11470347
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/470347 | AMINOPURINE DERIVATIVES FOR TREATING NEURODEGENERATIVE DISEASES | Sep 5, 2006 | Abandoned |